Table 2.
Method | Performance measure | |||||
---|---|---|---|---|---|---|
Patients P1-P5 | Patients P6-P8 | |||||
k-CL | 0.49 | 0.61 | −0.21 | 0.37 | 0.52 | −0.25 |
PCA | 0.25 | 0.44 | −0.13 | 0.19 | 0.31 | −0.15 |
l0-DL | 0.49 | 0.50 | −0.29 | 0.30 | 0.28 | −0.38 |
l0-DLCL | 0.52 | 0.53 | −0.34 | 0.38 | 0.26 | −0.47 |
l0-DLPCA | 0.34 | 0.39 | −0.23 | 0.34 | 0.18 | −0.26 |
l1-DL | 0.51 | 0.62 | −0.27 | 0.35 | 0.54 | −0.31 |
l1-DLCL | 0.51 | 0.60 | −0.30 | 0.38 | 0.23 | −0.34 |
l 1 -DL PCA | 0.53 | 0.67 | −0.25 | 0.38 | 0.54 | −0.31 |
The highest values for each correlation coefficient are highlighted in bold. l1-DLPCA consistently yielded the highest and for patients P1-P5, thus being deemed the best method; the same was subsequently observed for patients P6-P8. Overall, PCA was clearly outperformed by k-CL and the DL approaches, the latter slightly surpassing k-CL.